Acima Private Wealth, LLC Relmada Therapeutics, Inc. Transaction History
Acima Private Wealth, LLC
- $271 Billion
- Q1 2024
A detailed history of Acima Private Wealth, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Acima Private Wealth, LLC holds 1,844 shares of RLMD stock, worth $7,246. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,844
Previous 1,844
-0.0%
Holding current value
$7,246
Previous $7.63 Million
12.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RLMD
# of Institutions
97Shares Held
14.2MCall Options Held
82KPut Options Held
73.9K-
Vanguard Group Inc Valley Forge, PA1.26MShares$4.94 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.24MShares$4.87 Million0.19% of portfolio
-
Vestal Point Capital, LP New York, NY1.2MShares$4.72 Million0.46% of portfolio
-
Acadian Asset Management LLC Boston, MA1.18MShares$4.64 Million0.02% of portfolio
-
Parsons Capital Management Inc976KShares$3.84 Million0.2% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $112M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...